Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of $939.79 million. The enterprise value is $984.23 million.

Market Cap	939.79M
Enterprise Value	984.23M

Important Dates

The next estimated earnings date is Wednesday, August 28, 2024, after market close.

Earnings Date	Aug 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Mesoblast has 127.00 million shares outstanding.

Shares Outstanding	127.00M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.05%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	833.33
PS Ratio	129.57
Forward PS	24.88
PB Ratio	1.85
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	135.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.24.

Current Ratio	2.72
Quick Ratio	2.60
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.71

Financial Efficiency

Return on equity (ROE) is -14.50% and return on invested capital (ROIC) is -9.33%.

Return on Equity (ROE)	-14.50%
Return on Assets (ROA)	-10.90%
Return on Capital (ROIC)	-9.33%
Revenue Per Employee	$87,386
Profits Per Employee	-$880,217
Employee Count	83
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-188,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.84% in the last 52 weeks. The beta is 2.45, so Mesoblast's price volatility has been higher than the market average.

Beta (5Y)	2.45
52-Week Price Change	-10.84%
50-Day Moving Average	7.39
200-Day Moving Average	4.19
Relative Strength Index (RSI)	49.81
Average Volume (20 Days)	221,002

Short Selling Information

Short Interest	373,263
Short Previous Month	460,516
Short % of Shares Out	1.14%
Short % of Float	n/a
Short Ratio (days to cover)	2.49

Income Statement

In the last 12 months, Mesoblast had revenue of $7.25 million and -$73.06 million in losses. Loss per share was -$0.91.

Revenue	7.25M
Gross Profit	7.25M
Operating Income	-58.88M
Pretax Income	-73.25M
Net Income	-73.06M
EBITDA	n/a
EBIT	-53.49M
Loss Per Share	-$0.91

Full Income Statement

Balance Sheet

The company has $77.55 million in cash and $122.00 million in debt, giving a net cash position of -$44.45 million or -$0.35 per share.

Cash & Cash Equivalents	77.55M
Total Debt	122.00M
Net Cash	-44.45M
Net Cash Per Share	-$0.35
Equity (Book Value)	508.73M
Book Value Per Share	4.01
Working Capital	53.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.10 million and capital expenditures -$231,000, giving a free cash flow of -$59.33 million.

Operating Cash Flow	-59.10M
Capital Expenditures	-231,000
Free Cash Flow	-59.33M
FCF Per Share	-$0.73

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -811.75% and -1,007.28%.

Gross Margin	100.00%
Operating Margin	-811.75%
Pretax Margin	-1,009.87%
Profit Margin	-1,007.28%
EBITDA Margin	n/a
EBIT Margin	-737.49%
FCF Margin	-818.02%

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.17%
Shareholder Yield	-25.17%
Earnings Yield	-7.77%
FCF Yield	-6.31%

Analyst Forecast

The average price target for Mesoblast is $8.50, which is 14.87% higher than the current price. The consensus rating is "Hold".

Price Target	$8.50
Price Target Difference	14.87%
Analyst Consensus	Hold
Analyst Count	6
Revenue Growth Forecast (5Y)	118.94%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 10, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date	Jan 10, 2024
Split Type	Reverse
Split Ratio	1:2

Scores

Mesoblast has an Altman Z-Score of 1.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.55
Piotroski F-Score	2